Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

28
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
28
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

42
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Therapy-refractory hepatic encephalopathy or acquired hepato-cerebral degeneration - a challenging differential diagnosis].

Zeitschrift fur Gastroenterologie·2026
Same author

Comparative performance of ReMELD-Na, MELD 3.0 and established scores after TIPS for refractory ascites: A multicenter study.

JHEP reports : innovation in hepatology·2026
Same author

Corrigendum to: "A rare vascular puzzle: Portal hypertension and hepatic lesions" [J Hepatol (2026) 84: e59-61].

Journal of hepatology·2026
Same author

Liver failure as first manifestation of a hepatic lymphoma.

Zeitschrift fur Gastroenterologie·2026
Same author

Performance of reMELD-Na as a predictor of short-term mortality in patients with cirrhosis and ascites.

JHEP reports : innovation in hepatology·2026
Same author

Corrigendum to 'Pre-emptive TIPS should be considered in high-risk patients with both acute variceal bleeding and severe alcohol-related hepatitis<sup>'</sup> (JHEP Reports 7 [2025] 101611).

JHEP reports : innovation in hepatology·2026
Same journal

A Rare Cause of Lower Gastrointestinal Bleeding: Multiple Myeloma.

Journal of gastrointestinal and liver diseases : JGLD·2026
Same journal

Double-Opening Submucosal Tunnel Endoscopic Resection for a Large Leiomyoma in the Cardia.

Journal of gastrointestinal and liver diseases : JGLD·2026
Same journal

An Unusual Intragastric Foreign Body: A Drainage Tube.

Journal of gastrointestinal and liver diseases : JGLD·2026
Same journal

An Interesting Endoscopic Description of Borderline Ischemia in Sigmoid Volvulus: The "Fallen Leaves in Autumn" Sign.

Journal of gastrointestinal and liver diseases : JGLD·2026
Same journal

Hemosuccus pancreaticus: a diagnostic pitfall in gastrointestinal bleeding.

Journal of gastrointestinal and liver diseases : JGLD·2026
Same journal

Colon Cleaning after Inadequate Bowel Preparation: A Pooleddata Analysis.

Journal of gastrointestinal and liver diseases : JGLD·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

11.6K

Machine Learning Models predicting Decompensation in Cirrhosis.

Sophie Elisabeth Müller1, Markus Casper2, Cristina Ripoll3

  • 1Department of Medicine II, Saarland University Medical Center, Saarland University, Homburg, Germany; Institute of Medical Microbiology and Hygiene, Center for Infectious Diseases, Saarland University, Homburg, Germany. sophieelisabeth.mueller@uks.eu.

Journal of Gastrointestinal and Liver Diseases : JGLD
|March 28, 2025
PubMed
Summary
This summary is machine-generated.

Machine learning models can predict cirrhosis decompensation using laboratory, clinical, and genetic data. Key predictors include albumin, bilirubin, and NOD2 genotype, aiding in early risk identification.

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.1K
Author Spotlight: Evaluating Therapeutic Strategies to Enhance Liver Regeneration
05:25

Author Spotlight: Evaluating Therapeutic Strategies to Enhance Liver Regeneration

Published on: May 24, 2024

1.4K

Related Experiment Videos

Last Updated: May 5, 2026

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

11.6K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.1K
Author Spotlight: Evaluating Therapeutic Strategies to Enhance Liver Regeneration
05:25

Author Spotlight: Evaluating Therapeutic Strategies to Enhance Liver Regeneration

Published on: May 24, 2024

1.4K

Area of Science:

  • Hepatology
  • Machine Learning in Medicine
  • Biostatistics

Background:

  • Cirrhosis decompensation significantly reduces patient survival.
  • Preventing cirrhosis complications is crucial for improving outcomes.
  • Machine learning offers novel approaches to predict decompensation risk.

Purpose of the Study:

  • To identify key parameters predicting cirrhosis decompensation using machine learning.
  • To evaluate the performance of different machine learning models in predicting decompensation.
  • To explore the utility of laboratory, clinical, and genetic data in risk prediction.

Main Methods:

  • Applied various machine learning techniques (Random Forests, Support Vector Machines) to a database of 983 patients.
  • Utilized hierarchical clustering and Permutation Feature Importance for parameter evaluation.
  • Analyzed retrospective and prospective data, including laboratory, clinical, and genetic information.

Main Results:

  • Random Forests achieved 81.6% accuracy retrospectively; Support Vector Machines achieved 78.6% prospectively.
  • Key predictors identified include baseline albumin, baseline bilirubin, and maximum bilirubin.
  • NOD2 genotype and inflammatory markers were significant predictors beyond established score parameters.

Conclusions:

  • Laboratory parameters, genetic variants, and infections are valuable in predicting cirrhosis decompensation risk.
  • This study provides a foundation for developing advanced predictive models.
  • Early identification of high-risk patients can facilitate timely interventions.